| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 1.33e-05 | 3 | 44 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 4.43e-05 | 5 | 44 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | acrosome assembly | 6.16e-05 | 36 | 44 | 3 | GO:0001675 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 6.59e-05 | 854 | 44 | 9 | GO:1903047 | |
| GeneOntologyBiologicalProcess | meiotic metaphase chromosome alignment | 6.64e-05 | 6 | 44 | 2 | GO:0051311 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 9.57e-05 | 217 | 44 | 5 | GO:0000075 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 2.18e-04 | 1235 | 44 | 10 | GO:0003006 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 2.42e-04 | 1014 | 44 | 9 | GO:0000278 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 2.46e-04 | 596 | 44 | 7 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle phase transition | 2.90e-04 | 12 | 44 | 2 | GO:1901993 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 3.34e-04 | 627 | 44 | 7 | GO:0044770 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 3.67e-04 | 845 | 44 | 8 | GO:0010564 | |
| GeneOntologyBiologicalProcess | membrane protein intracellular domain proteolysis | 3.98e-04 | 14 | 44 | 2 | GO:0031293 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 3.99e-04 | 163 | 44 | 4 | GO:0007093 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle phase transition | 4.59e-04 | 15 | 44 | 2 | GO:0044771 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 5.06e-04 | 311 | 44 | 5 | GO:1901988 | |
| GeneOntologyBiologicalProcess | germ cell development | 5.25e-04 | 482 | 44 | 6 | GO:0007281 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 5.83e-04 | 906 | 44 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | secretory granule organization | 6.16e-04 | 78 | 44 | 3 | GO:0033363 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 6.87e-04 | 929 | 44 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 6.98e-04 | 509 | 44 | 6 | GO:0044772 | |
| GeneOntologyBiologicalProcess | cellular response to hepatocyte growth factor stimulus | 7.43e-04 | 19 | 44 | 2 | GO:0035729 | |
| GeneOntologyBiologicalProcess | cell cycle process | 7.44e-04 | 1441 | 44 | 10 | GO:0022402 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 7.50e-04 | 516 | 44 | 6 | GO:1901987 | |
| GeneOntologyCellularComponent | inner acrosomal membrane | 6.76e-05 | 6 | 45 | 2 | GO:0002079 | |
| Domain | UIM | 6.70e-04 | 18 | 40 | 2 | PF02809 | |
| Domain | UIM | 9.15e-04 | 21 | 40 | 2 | SM00726 | |
| Domain | UIM | 1.20e-03 | 24 | 40 | 2 | PS50330 | |
| Domain | UIM_dom | 1.30e-03 | 25 | 40 | 2 | IPR003903 | |
| Domain | Cadherin_CS | 1.63e-03 | 109 | 40 | 3 | IPR020894 | |
| Domain | Cadherin | 1.81e-03 | 113 | 40 | 3 | PF00028 | |
| Domain | CADHERIN_1 | 1.81e-03 | 113 | 40 | 3 | PS00232 | |
| Domain | CADHERIN_2 | 1.86e-03 | 114 | 40 | 3 | PS50268 | |
| Domain | - | 1.86e-03 | 114 | 40 | 3 | 2.60.40.60 | |
| Domain | CA | 1.90e-03 | 115 | 40 | 3 | SM00112 | |
| Domain | Cadherin-like | 1.95e-03 | 116 | 40 | 3 | IPR015919 | |
| Domain | Cadherin | 2.05e-03 | 118 | 40 | 3 | IPR002126 | |
| Domain | WW | 4.55e-03 | 47 | 40 | 2 | PF00397 | |
| Domain | WW | 4.74e-03 | 48 | 40 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 5.34e-03 | 51 | 40 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 5.34e-03 | 51 | 40 | 2 | PS01159 | |
| Domain | WW_dom | 5.54e-03 | 52 | 40 | 2 | IPR001202 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.75e-03 | 53 | 40 | 2 | IPR011047 | |
| Domain | EGF_extracell | 7.32e-03 | 60 | 40 | 2 | IPR013111 | |
| Domain | EGF_2 | 7.32e-03 | 60 | 40 | 2 | PF07974 | |
| Domain | USP_CS | 8.80e-03 | 66 | 40 | 2 | IPR018200 | |
| Domain | USP_1 | 9.85e-03 | 70 | 40 | 2 | PS00972 | |
| Domain | UCH | 1.01e-02 | 71 | 40 | 2 | PF00443 | |
| Domain | USP_2 | 1.01e-02 | 71 | 40 | 2 | PS00973 | |
| Domain | USP_3 | 1.04e-02 | 72 | 40 | 2 | PS50235 | |
| Domain | USP_dom | 1.04e-02 | 72 | 40 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.04e-02 | 72 | 40 | 2 | IPR001394 | |
| Domain | EGF_3 | 1.38e-02 | 235 | 40 | 3 | PS50026 | |
| Domain | EGF | 1.38e-02 | 235 | 40 | 3 | SM00181 | |
| Pubmed | USP37 Promotes Lung Cancer Cell Migration by Stabilizing Snail Protein via Deubiquitination. | 1.71e-06 | 2 | 46 | 2 | 31998374 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 33391500 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 20534451 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 28648644 | ||
| Pubmed | 1.81e-05 | 418 | 46 | 6 | 34709266 | ||
| Pubmed | From midbody protein-protein interaction network construction to novel regulators in cytokinesis. | 2.56e-05 | 6 | 46 | 2 | 19799413 | |
| Pubmed | 4.56e-05 | 493 | 46 | 6 | 15368895 | ||
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 12140191 | ||
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 20301772 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.53e-04 | 232 | 46 | 4 | 25515538 | |
| Pubmed | 3.11e-04 | 99 | 46 | 3 | 34161765 | ||
| Pubmed | 3.30e-04 | 101 | 46 | 3 | 10997877 | ||
| Pubmed | 3.89e-04 | 22 | 46 | 2 | 24310815 | ||
| Pubmed | 3.90e-04 | 107 | 46 | 3 | 11347906 | ||
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 4.25e-04 | 23 | 46 | 2 | 14715245 | |
| Pubmed | 4.64e-04 | 24 | 46 | 2 | 31911859 | ||
| Pubmed | 5.28e-04 | 282 | 46 | 4 | 23667531 | ||
| Pubmed | 5.45e-04 | 26 | 46 | 2 | 28087629 | ||
| Pubmed | 5.88e-04 | 27 | 46 | 2 | 31308417 | ||
| Pubmed | 6.33e-04 | 28 | 46 | 2 | 24322204 | ||
| Pubmed | 6.33e-04 | 28 | 46 | 2 | 28159809 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 7.52e-04 | 134 | 46 | 3 | 25452129 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 8.28e-04 | 32 | 46 | 2 | 25189868 | |
| Pubmed | 8.28e-04 | 32 | 46 | 2 | 33669244 | ||
| Pubmed | 9.38e-04 | 329 | 46 | 4 | 17474147 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 9.58e-04 | 1203 | 46 | 7 | 29180619 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.05e-03 | 588 | 46 | 5 | 38580884 | |
| Pubmed | 1.08e-03 | 152 | 46 | 3 | 34299191 | ||
| Interaction | NAA11 interactions | 1.01e-05 | 62 | 44 | 4 | int:NAA11 | |
| Cytoband | 1p32 | 3.39e-04 | 27 | 46 | 2 | 1p32 | |
| GeneFamily | Cadherin related | 3.81e-04 | 17 | 31 | 2 | 24 | |
| GeneFamily | Ubiquitin specific peptidases | 4.14e-03 | 56 | 31 | 2 | 366 | |
| GeneFamily | Ankyrin repeat domain containing | 8.07e-03 | 242 | 31 | 3 | 403 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-06 | 199 | 46 | 5 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-06 | 199 | 46 | 5 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-06 | 199 | 46 | 5 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 2.08e-05 | 157 | 46 | 4 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.58e-05 | 166 | 46 | 4 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 167 | 46 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 169 | 46 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-05 | 171 | 46 | 4 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-05 | 171 | 46 | 4 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-05 | 171 | 46 | 4 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-05 | 178 | 46 | 4 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 179 | 46 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-05 | 186 | 46 | 4 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.03e-05 | 186 | 46 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 187 | 46 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 4.20e-05 | 188 | 46 | 4 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.20e-05 | 188 | 46 | 4 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 4.38e-05 | 190 | 46 | 4 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 4.47e-05 | 191 | 46 | 4 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.65e-05 | 193 | 46 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-05 | 193 | 46 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.75e-05 | 194 | 46 | 4 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.75e-05 | 194 | 46 | 4 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.75e-05 | 194 | 46 | 4 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 4.75e-05 | 194 | 46 | 4 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 4.75e-05 | 194 | 46 | 4 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.75e-05 | 194 | 46 | 4 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 4.84e-05 | 195 | 46 | 4 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 195 | 46 | 4 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.84e-05 | 195 | 46 | 4 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 4.94e-05 | 196 | 46 | 4 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 4.94e-05 | 196 | 46 | 4 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.94e-05 | 196 | 46 | 4 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-05 | 197 | 46 | 4 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.04e-05 | 197 | 46 | 4 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-05 | 197 | 46 | 4 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 5.04e-05 | 197 | 46 | 4 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 5.04e-05 | 197 | 46 | 4 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-05 | 197 | 46 | 4 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 5.04e-05 | 197 | 46 | 4 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 5.14e-05 | 198 | 46 | 4 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-05 | 198 | 46 | 4 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 5.14e-05 | 198 | 46 | 4 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-05 | 198 | 46 | 4 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.14e-05 | 198 | 46 | 4 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.14e-05 | 198 | 46 | 4 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 5.14e-05 | 198 | 46 | 4 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 5.14e-05 | 198 | 46 | 4 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-05 | 198 | 46 | 4 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.14e-05 | 198 | 46 | 4 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.24e-05 | 199 | 46 | 4 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-05 | 199 | 46 | 4 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 5.24e-05 | 199 | 46 | 4 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.24e-05 | 199 | 46 | 4 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.24e-05 | 199 | 46 | 4 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 5.24e-05 | 199 | 46 | 4 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-05 | 199 | 46 | 4 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 5.24e-05 | 199 | 46 | 4 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 5.24e-05 | 199 | 46 | 4 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.24e-05 | 199 | 46 | 4 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 5.24e-05 | 199 | 46 | 4 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.24e-05 | 199 | 46 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.24e-05 | 199 | 46 | 4 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-05 | 199 | 46 | 4 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.24e-05 | 199 | 46 | 4 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.34e-05 | 200 | 46 | 4 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.34e-05 | 200 | 46 | 4 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 46 | 4 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.34e-05 | 200 | 46 | 4 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.34e-05 | 200 | 46 | 4 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Pvalb_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.98e-05 | 87 | 46 | 3 | fd0df79b02f96463a6bad90dcd019c59c8e3eb0e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 103 | 46 | 3 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 117 | 46 | 3 | 26dec09112532f351fb7a2202bae84c365707b40 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 117 | 46 | 3 | db053c874e6739052dff1f91643e51b306236237 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 117 | 46 | 3 | 80780223502d18f0d86a29ff3cb74aa8235103c7 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 117 | 46 | 3 | 40889f4a387846abbf54469cc4faf616bfe348d0 | |
| ToppCell | Striatum-Macroglia-CSF_related|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 117 | 46 | 3 | e12e37e393257db85f7f5c13454095c44f59d374 | |
| ToppCell | COVID-19_Mild-immature_Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 2.78e-04 | 123 | 46 | 3 | 5f19b0e32509bedeb9ac6c74ac7a20750798da5e | |
| ToppCell | COVID-19_Mild-immature_Neutrophil|COVID-19_Mild / Disease condition and Cell class | 2.78e-04 | 123 | 46 | 3 | a6670825fd8d9f9a0111a7b68598c764c99abb0d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.84e-04 | 124 | 46 | 3 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.98e-04 | 126 | 46 | 3 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-04 | 126 | 46 | 3 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.73e-04 | 136 | 46 | 3 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 5.26e-04 | 153 | 46 | 3 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.36e-04 | 154 | 46 | 3 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.88e-04 | 159 | 46 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.88e-04 | 159 | 46 | 3 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 159 | 46 | 3 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.88e-04 | 159 | 46 | 3 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 159 | 46 | 3 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-04 | 162 | 46 | 3 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.32e-04 | 163 | 46 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-04 | 163 | 46 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-04 | 165 | 46 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| Disease | Prostatic Neoplasms | 3.81e-05 | 616 | 45 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.81e-05 | 616 | 45 | 7 | C0376358 | |
| Disease | Autosomal recessive primary microcephaly | 2.36e-04 | 15 | 45 | 2 | cv:C3711387 | |
| Disease | Primary microcephaly | 5.15e-04 | 22 | 45 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 5.15e-04 | 22 | 45 | 2 | C3711387 | |
| Disease | suicidal ideation | 8.99e-04 | 29 | 45 | 2 | EFO_0004320 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTEAASSKQLENQNP | 1036 | Q14146 | |
| PKFTSQDSPDGQYEN | 641 | P56945 | |
| NPESNYCLKNDVSNP | 106 | P07327 | |
| NNPQLKESLDPNTSY | 26 | Q9P2G1 | |
| SEYKENETPRNPQNS | 221 | Q6NSI1 | |
| NDNNPIFDQPSYQEA | 2396 | Q9H251 | |
| SAASDYPQQNKAAAD | 261 | Q8N0U7 | |
| AFNPDPKSEYNDQLT | 136 | P23786 | |
| QTDPNPNESHEKQYE | 6 | O75747 | |
| KLYSQDSQSPAAQQE | 291 | Q7Z3D4 | |
| NNPSSDYPSDFEVIQ | 91 | Q14703 | |
| VDPQSNDPSQSDKQD | 326 | Q96MR6 | |
| TDENDNPPQFKASEY | 2576 | Q9NYQ8 | |
| KEIEPNYESPSSNNQ | 381 | Q9H792 | |
| PYLDKDSPQSADCNQ | 676 | Q8NG31 | |
| NVDNKNYGSPINPSE | 4546 | P98164 | |
| DVNDNAPAFAQPQYT | 446 | Q9Y5H7 | |
| ENNFENPKNTDTYIP | 271 | Q16821 | |
| APYPFAVENQNEAEN | 106 | Q9HBI5 | |
| PAEESEHKNNNYEPN | 46 | P51587 | |
| EYFNSKEQNPSPLNG | 341 | Q9P2H0 | |
| EDSSKGQEPNDTNQY | 301 | Q8NBF6 | |
| ESNNPYKPQSDKSET | 81 | Q9HC77 | |
| YESDGKNQANPSRQP | 736 | Q13443 | |
| DSKKQDPDEQSYSNN | 126 | Q6QHK4 | |
| SQPESKASNFAQPED | 331 | Q8NDH2 | |
| DHTPNYAPANEKNGN | 46 | Q9NQ60 | |
| DYKPTNKSNAPSENN | 601 | Q6P3S1 | |
| TENNDSETAENYAPP | 51 | Q9HBV2 | |
| FQTNNNENPYTDPAD | 826 | Q15648 | |
| GSDYEQPLEVKNNSN | 56 | P30304 | |
| AENYKSQQSSDPDPN | 431 | P02788 | |
| DASSNYTPQDPARNE | 1026 | Q9HCM1 | |
| KPQDPQGQEATDSEY | 456 | Q9NYZ4 | |
| NPSNNPSKTSDAPYD | 116 | Q9BTA9 | |
| EGPTIKNDASQQTNY | 171 | Q9Y228 | |
| SDPNRKPNYSELQDS | 11 | O95863 | |
| KPNYSELQDSNPEFT | 16 | O95863 | |
| PPDNADSKSEYLLNQ | 1141 | Q15468 | |
| KASESSDPSAYQNQP | 6 | Q9H9J4 | |
| NNEEAESKQNPGSIY | 76 | B1AK76 | |
| SDTNDALQKNSNPYI | 346 | Q63HK5 | |
| DFSQEKPSTTYQQPD | 1261 | Q9BYW2 | |
| ELNTPQSPKDAYENT | 451 | Q8NEG5 | |
| NEDYPKENDSSSNNK | 216 | Q86T82 | |
| SNDSSYSEPPDVQQQ | 2141 | Q96JM2 | |
| NPTEFDYLNPNVQDS | 531 | O15050 | |
| TPESQQFPDTENEQY | 491 | Q6S545 | |
| YAAPEQNNDPQQSKV | 801 | Q8NI36 |